Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Autoimmune Disorders

  Free Subscription


Articles published in Int J Clin Pract

Retrieve available abstracts of 28 articles:
HTML format



Single Articles


    October 2021
  1. LEE LE, Pyo JY, Ahn SS, Song JJ, et al
    Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis.
    Int J Clin Pract. 2021;75:e14512.
    PubMed     Abstract available


    September 2021
  2. BILGINER MC, Faki S, Ozdemir D, Baser H, et al
    Organ-specific autoimmune markers in adult patients with type 1 diabetes mellitus.
    Int J Clin Pract. 2021 Sep 22:e14842. doi: 10.1111/ijcp.14842.
    PubMed     Abstract available


  3. GAO R, Kong L, Qing P, Cheng K, et al
    Interleukin-1 beta as Clinically Predictive Risk Marker for Recurrent Pregnancy Loss in Women Positive for Antinuclear Antibody.
    Int J Clin Pract. 2021 Sep 19:e14887. doi: 10.1111/ijcp.14887.
    PubMed     Abstract available


  4. AKAN O, Polat EC, Culha MG, Onol SD, et al
    The Impact of Myasthenia Gravis on Lower Urinary Tract Functions.
    Int J Clin Pract. 2021 Sep 15:e14873. doi: 10.1111/ijcp.14873.
    PubMed     Abstract available


  5. GEZMIS H, Mayda Domac F, Ormeci B, Uyanik H, et al
    epsilon2 , epsilon3 , and epsilon4 variants of ApoE; rs2228570 (VDR), rs4588 and rs7041 (VDBP) polymorphisms in patients with multiple sclerosis: A case-control study in Turkish population.
    Int J Clin Pract. 2021 Sep 6:e14801. doi: 10.1111/ijcp.14801.
    PubMed     Abstract available


    August 2021
  6. SAHIN EDIZ S, Atalay B, Aydin Canturk I, Kabaalioglu A, et al
    Assessment of the optic nerve, optic disc, and perineural area using shear-wave elastography in patients with multiple sclerosis.
    Int J Clin Pract. 2021 Aug 15:e14736. doi: 10.1111/ijcp.14736.
    PubMed     Abstract available


  7. MIRASHRAFI S, Hejazi Taghanaki SZ, Sarlak F, Moravejolahkami AR, et al
    Effect of Probiotics Supplementation on Disease Progression, Depression, General Health and Anthropometric Measurements in Relapsing-Remitting Multiple Sclerosis Patients: A Systematic Review and Meta-analysis of Clinical Trials.
    Int J Clin Pract. 2021 Aug 11:e14724. doi: 10.1111/ijcp.14724.
    PubMed     Abstract available


    July 2021
  8. UZKESER H, Keskin H, Haliloglu S, Cayir Y, et al
    Is Mean Platelet Volume Related to Disease Activity in Systemic Lupus Erythematosus?
    Int J Clin Pract. 2021 Jul 29:e14676. doi: 10.1111/ijcp.14676.
    PubMed     Abstract available


  9. UZUNKOPRU C, Tutuncu M, Gunduz T, Gumus H, et al
    The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey.
    Int J Clin Pract. 2021;75:e14158.
    PubMed     Abstract available


    June 2021
  10. KRYCZYK-KOZIOL J, Zagrodzki P, Prochownik E, Blazewska-Gruszczyk A, et al
    Positive effects of selenium supplementation in women with newly diagnosed Hashimoto's thyroiditis in an area with low selenium status.
    Int J Clin Pract. 2021 Jun 9:e14484. doi: 10.1111/ijcp.14484.
    PubMed     Abstract available


    May 2021
  11. OKA S, Ono K, Nohgawa M
    The association of lymphocyte phenotypes and outcomes after discontinuing eltrombopag in immune thrombocytopenia.
    Int J Clin Pract. 2021;75:e14057.
    PubMed     Abstract available


    April 2021
  12. OZBEN S, Kucuksayan E, Koseoglu M, Erel O, et al
    Plasma Thiol/Disulphide Homeostasis Changes In Patients With Relapsing-Remitting Multiple Sclerosis.
    Int J Clin Pract. 2021 Apr 23:e14241. doi: 10.1111/ijcp.14241.
    PubMed     Abstract available


  13. GEZMIS H, Doran T, Mayda Domac F, Yucel D, et al
    CD4+ and CD25+ T cell response to short-time interferon-beta therapy on IL10, IL23A and FOXP3 genes in multiple sclerosis patients.
    Int J Clin Pract. 2021 Apr 22:e14238. doi: 10.1111/ijcp.14238.
    PubMed     Abstract available


  14. NABATIAN-ASL M, Ghorbanihaghjo A, Malek Mahdavi A, Khabbazi A, et al
    Effects of Melatonin Supplementation on Serum Oxidative Stress Markers and Disease Activity in Systemic Lupus Erythematosus Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Int J Clin Pract. 2021 Apr 20:e14246. doi: 10.1111/ijcp.14246.
    PubMed     Abstract available


  15. PYO JY, Ahn SS, Lee LE, Choe HN, et al
    Efficacy of the fibrosis index for predicting end-stage renal disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Int J Clin Pract. 2021;75:e13929.
    PubMed     Abstract available


    March 2021
  16. WU S, Tang X, Wu L, Lu L, et al
    Anti-Ro52 antibodies in clinical practice: A single-centre experience.
    Int J Clin Pract. 2021;75:e13679.
    PubMed     Abstract available


    January 2021
  17. EL-ZAWAWY HT, Ahmed SM, El-Attar EA, Ahmed AAE, et al
    Study Of The Gut Microbiome In Egyptian Patients With Autoimmune Thyroid Diseases.
    Int J Clin Pract. 2021 Jan 22:e14038. doi: 10.1111/ijcp.14038.
    PubMed     Abstract available


    December 2020
  18. NIKFAR M, Malek Mahdavi A, Khabbazi A, Hajialilo M, et al
    Long-term remission in patients with systemic lupus erythematosus.
    Int J Clin Pract. 2020 Dec 5:e13909. doi: 10.1111/ijcp.13909.
    PubMed     Abstract available


    November 2020
  19. KAYA B, Paydas S, Balal M, Eren Erdogan K, et al
    Renal expression of PLA2R, THSD7A, and IgG4 in patients with membranous nephropathy and correlation with clinical findings.
    Int J Clin Pract. 2020 Nov 29:e13855. doi: 10.1111/ijcp.13855.
    PubMed     Abstract available


    October 2020
  20. PRZYDACZ M, Dudek P, Golabek T, Choragwicki D, et al
    Neurogenic bladder symptom score: Polish translation, adaptation and validation of urinary disorder-specific instrument for patients with neurogenic lower urinary tract dysfunction.
    Int J Clin Pract. 2020;74:e13582.
    PubMed     Abstract available


    September 2020
  21. KAYA B, Paydas S, Kuzu T, Basak Tanburoglu D, et al
    Primary glomerulonephritis in diabetic patients.
    Int J Clin Pract. 2020 Sep 21:e13713. doi: 10.1111/ijcp.13713.
    PubMed     Abstract available


  22. EBRAHIMIAN S, Rashtchizadeh N, Ghorbanihaghjo A, Malek Mahdavi A, et al
    Association between serum levels of survivin and systemic lupus erythematosus.
    Int J Clin Pract. 2020 Sep 15:e13706. doi: 10.1111/ijcp.13706.
    PubMed     Abstract available


    July 2020
  23. BELESLIN BN, Ciric J, Stojkovic M, Savic S, et al
    Comparison of efficacy and safety of parenteral vs parenteral and oral glucocorticoid therapy in Graves' orbitopathy.
    Int J Clin Pract. 2020 Jul 10:e13608. doi: 10.1111/ijcp.13608.
    PubMed     Abstract available


    January 2020
  24. KWON HC, Ahn SS, Jung SM, Song JJ, et al
    Clinical implication of chronic paranasal sinusitis for the classification of microscopic polyangiitis.
    Int J Clin Pract. 2020;74:e13431.
    PubMed     Abstract available


    November 2019
  25. KRISTENSEN PL
    Physical activity and type 1 diabetes: Moving from the laboratory to the real world.
    Int J Clin Pract. 2019;73:e13396.
    PubMed    


  26. HOHENDORFF J, Ucieklak D, Skupien J, Matejko B, et al
    Risk factors of hypoglycaemia in type 1 diabetes individuals during intensive sport exercise-Data from the SPORTGIVECHANCE event.
    Int J Clin Pract. 2019;73:e13411.
    PubMed     Abstract available


    December 2018
  27. KLEIN OA, Nair RD, Ablewhite J, Drummond A, et al
    Assessment and Management of Cognitive Problems in People with Multiple Sclerosis: A National Survey of Clinical Practice.
    Int J Clin Pract. 2018 Dec 3:e13300. doi: 10.1111/ijcp.13300.
    PubMed     Abstract available


  28. HEALD AH, Livingston M, Fryer A, Cortes G, et al
    Real-world practice level data analysis confirms link between variability within Blood Glucose Monitoring Strip (BGMS) and glycosylated haemoglobin (HbA1c) in Type 1 Diabetes.
    Int J Clin Pract. 2018;72:e13252.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: